STTR grant

The company said the NIH funding will enable it to further validate the saliva-based test and prepare it for commercial launch later this year.

The firm will use the funds to develop its Singulator system, which uses single-use sample cartridges and reagents to rapidly isolate cells and nuclei.

Proposed increases to small business programs touch off fight between business and research groups, ScienceInsider reports.

The partners will augment the multiplexing capabilities of ICE COLD-PCR, which was developed at Dana-Farber and is exclusively licensed to Transgenomic.

The test detects a signature molecular marker upregulated by viable bacteria, and will be useful for pediatric, extrapulmonary, and AIDS-related TB.

NEW YORK (GenomeWeb News) – Diffinity Genomics has won a pair of grants worth a total of $700,000 from the National Institutes of Health to support the company's ongoing development of new technologies and products for rapid nucleic acid purification using specialized pipette tips.

The NIH wants to fuel development of new proteomics technologies and glycomics tools through its SBIR/STTR program.

Pages

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.